Alkem Laboratories Announces Board Meeting to Approve Unaudited Financial Results for Quarter Ending June 30, 2026
Alkem Laboratories Ltd has scheduled a meeting of its Board of Directors to review and approve the Standalone and Consolidated Unaudited Financial Results for the quarter ended June 30, 2026.The company announced that the Board meeting is slated to take place on Friday, August 14, 2026. The primary agenda item for the meeting includes considering and formally approving the unaudited financial performance of the organization for the specified period.
ALKEM Stock Price Movement
Alkem Laboratories Limited shares closed higher today, edging up 0.63% to settle at ₹5,689 after trading saw a volume of 27,882 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.